Form 4 for CNTX Context Therapeutics Inc.
Accepted 2023-01-30 00:00:00 ET · period of report 2023-01-30 · accession 0001842952-23-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-30 | 2023-01-30 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.7 | +7,027 | 143.2K | +5% | +$4,919 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-30 | P | A | 7,027 | $0.7 | 143,232 | D | — | — | (F2) The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.682 - $0.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. |